Clinical Trial Update: AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing AV-GBM-1 to control as adjunctive therapy after surgery and standard treatment for newly diagnosed primary glioblastoma; not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• AV-GBM-1

Snippet

Sponsor: Aivita Biomedical, Inc. | Conditions: Primary Glioblastoma | Phase 3 | Status: NOT_YET_RECRUITING